Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccinology update 2004].

C A Siegrist1

  • 1Directrice du Département de pédiatrie, Centre de vaccinologie et d'immunologie néonatale, Université de Genève, CMU, I, rue Michel-Servet, 1211 Genève 4. Claire-Anne.Siegrist@medecine.unige.ch

Revue Medicale Suisse
|March 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference center.

Pediatric transplantation·2011
Same author

[Diagnosis, treatment and prevention of measles].

Revue medicale suisse·2008
Same author

[First glance at the 2007 national immunization plan].

Revue medicale suisse·2007
Same author

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins.

Vaccine·2006
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

In 2004, Swiss vaccine strategies adapted to ongoing measles risks, improving identification of high-risk patients for infectious diseases like chickenpox. Updated vaccine formulations and new clinical data were also introduced.

Area of Science:

  • Public Health
  • Vaccinology
  • Infectious Disease Epidemiology

Context:

  • Persistent measles risk in Switzerland necessitated strategy adaptation in 2004.
  • Need for better identification of individuals at high risk for infectious disease complications.
  • Introduction of novel vaccine formulations and updated clinical data.

Purpose:

  • To adapt national vaccine strategies in response to evolving public health challenges.
  • To enhance the identification of at-risk populations for vaccine-preventable diseases.
  • To incorporate new clinical evidence and updated vaccine formulations into practice.

Summary:

  • Key changes in 2004 included adapting measles vaccination strategies (infant immunization, catch-up to age 40) and defining high-risk groups for chickenpox complications.

Related Experiment Videos

  • Novel vaccine formulations replaced older ones, supported by new clinical study data.
  • The physician resource www.infovac.ch remained available for vaccination inquiries.

    • Impact:

    • Improved public health response to measles outbreaks through targeted immunization.
    • Enhanced patient safety by identifying and managing risks for complications from diseases like chickenpox.
    • Facilitated informed clinical decision-making through updated vaccine information and formulations.